| __timestamp | ImmunityBio, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4326000 | 2917513 |
| Thursday, January 1, 2015 | 226206000 | 7878291 |
| Friday, January 1, 2016 | 94391000 | 8366794 |
| Sunday, January 1, 2017 | 53821000 | 6610381 |
| Monday, January 1, 2018 | 35463000 | 6556000 |
| Tuesday, January 1, 2019 | 46456000 | 6930000 |
| Wednesday, January 1, 2020 | 71318000 | 8758000 |
| Friday, January 1, 2021 | 135256000 | 10806000 |
| Saturday, January 1, 2022 | 102708000 | 9844000 |
| Sunday, January 1, 2023 | 129620000 | 13481000 |
Unleashing the power of data
In the competitive landscape of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. ImmunityBio, Inc. and Soleno Therapeutics, Inc. have shown contrasting approaches over the past decade. ImmunityBio's SG&A expenses have fluctuated significantly, peaking in 2015 with a staggering 2,262% increase from the previous year. In contrast, Soleno Therapeutics has maintained a more stable trajectory, with expenses growing modestly by about 362% over the same period.
From 2014 to 2023, ImmunityBio's average SG&A expenses were approximately 11 times higher than Soleno's, reflecting a more aggressive spending strategy. However, Soleno's consistent management might suggest a more sustainable approach. As the biotech industry evolves, these companies' financial strategies will play a pivotal role in their long-term success.
Johnson & Johnson or ImmunityBio, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Johnson & Johnson vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Sanofi or ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or ImmunityBio, Inc.
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Bio-Techne Corporation or ImmunityBio, Inc.
BioMarin Pharmaceutical Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Amneal Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Comparing SG&A Expenses: Perrigo Company plc vs Soleno Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Xenon Pharmaceuticals Inc. vs ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Iovance Biotherapeutics, Inc.
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and Soleno Therapeutics, Inc.